Insights

Niche NGS Medio Labs offers a scalable MedioSeq platform that converts qPCR workflows to a consolidated next-generation sequencing pipeline, enabling higher throughput and cost efficiency for pathogen detection labs. This presents a sales opportunity to labs seeking to modernize testing with reduced space, personnel, and instrument requirements.

Broad Applications Applications span human diagnostics, veterinary, agricultural, environmental, and food testing, which expands the addressable market for turnkey sequencing-based pathogen panels and cross-industry partnerships.

Pandemic Proven Experience processing thousands of Covid-19 samples per day demonstrates proven reliability and real-world scale, a compelling proof point when engaging labs considering a transition to NGS-based workflows.

Cost Throughput The value proposition centers on increasing throughput while lowering per-sample costs, appealing to labs facing budget constraints and the need to maximize panel capacity and test volume.

Growth Potential Small team footprint with ambitious technology indicates potential for rapid partnerships, channel collaborations, and pilot programs with larger labs seeking to optimize existing pathogen testing portfolios.

Similar companies to Medio Labs

Medio Labs Tech Stack

Medio Labs uses 8 technology products and services including Fullstory, Google Hosted Libraries, Open Graph, and more. Explore Medio Labs's tech stack below.

  • Analytics
  • Google Hosted Libraries
    Content Delivery Network
  • Open Graph
    Content Management System
  • Content Management System
  • E-commerce
  • Infrastructure As A Service
  • Platform As A Service
  • Google Analytics
    Web Analytics

Medio Labs's Email Address Formats

Medio Labs uses at least 2 email formats:
Medio Labs Email FormatsExamplePercentage
First@medio.aiJohn@medio.ai
88%
Last@medio.aiDoe@medio.ai
12%

Frequently Asked Questions

What is Medio Labs's official website and social media links?

Minus sign iconPlus sign icon
Medio Labs's official website is medio.ai and has social profiles on LinkedIn.

How much revenue does Medio Labs generate?

Minus sign iconPlus sign icon
As of October 2026, Medio Labs's annual revenue is estimated to be <$1M.

What is Medio Labs's SIC code and NAICS code?

Minus sign iconPlus sign icon
Medio Labs's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Medio Labs have currently?

Minus sign iconPlus sign icon
As of October 2026, Medio Labs has approximately 3 employees across 1 continents, including North America. Key team members include Co-Founder, Chief Executive Officer: Z. H. and Customer Success Manager: S. L. Explore Medio Labs's employee directory with LeadIQ.

What industry does Medio Labs belong to?

Minus sign iconPlus sign icon
Medio Labs operates in the Biotechnology Research industry.

What technology does Medio Labs use?

Minus sign iconPlus sign icon
Medio Labs's tech stack includes Fullstory, Google Hosted Libraries, Open Graph, WordPress, WooCommerce, Google Cloud, WP Engine and Google Analytics.

What is Medio Labs's email format?

Minus sign iconPlus sign icon
Medio Labs's email format typically follows the pattern of First@medio.ai. Find more Medio Labs email formats with LeadIQ.

When was Medio Labs founded?

Minus sign iconPlus sign icon
Medio Labs was founded in 2020.
Medio Labs logo

Medio Labs

Biotechnology ResearchCalifornia, United States2-10 Employees

Medio Labs is a biotechnology research company based in Emeryville, California, focused on improving pathogen testing workflows. Its patent-pending MedioSeq platform consolidates qPCR panels into a single sequencing-based workflow, enabling labs to process more panels and samples while reducing space, personnel, instruments, and consumables. MedioSeq has broad applications across human diagnostics and into veterinary, agricultural, environmental, and food testing.

Its primary customers are pathogen-detection laboratories seeking higher throughput and greater efficiency. During the Covid-19 pandemic, Medio Labs demonstrated the platform's capacity by processing large volumes of samples and continues to focus on scaling pathogen-panel workflows.

Section iconCompany Overview

Website
medio.ai
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
2-10

Section iconFunding & Financials

  • <$1M

    Medio Labs's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.